Abstract

Spindle cell haemangioma (SCH), formerly known as spindle cell haemangioendothelioma, is a rare benign vascular tumour characterised by reactive vascular proliferation.1 The lesions mostly occur in the dermis and subcutaneous tissue of distal extremities. SCH is more common in children and young adults than other age groups, and it is equally prevalent in the sexes. Histologically, proliferating spindle cells and cavernous blood vessels constitute the structure of SCH. SCH can present as vascular tumours in Maffucci's syndrome (MS). MS should be suspected when multifocal SCHs appear with enchondromas. This article is protected by copyright. All rights reserved.

Original languageEnglish
JournalBritish Journal of Dermatology
DOIs
Publication statusE-pub ahead of print - May 11 2018

Fingerprint

Sirolimus
Hemangioma
Blood Vessels
Enchondromatosis
Therapeutics
Hemangioendothelioma
Chondroma
Subcutaneous Tissue
Dermis
Young Adult
Neoplasms
Extremities
Age Groups

Cite this

Effective Sirolimus Treatment for Refractory Spindle Cell Haemangioma. / Ho, C B; Hsieh, K; Chen, W Y; Lin, Y T; Chiou, J F; Lee, H L; Shiah, H S.

In: British Journal of Dermatology, 11.05.2018.

Research output: Contribution to journalArticle

@article{4a506523e45945ed8e69d94865e7e1ea,
title = "Effective Sirolimus Treatment for Refractory Spindle Cell Haemangioma",
abstract = "Spindle cell haemangioma (SCH), formerly known as spindle cell haemangioendothelioma, is a rare benign vascular tumour characterised by reactive vascular proliferation.1 The lesions mostly occur in the dermis and subcutaneous tissue of distal extremities. SCH is more common in children and young adults than other age groups, and it is equally prevalent in the sexes. Histologically, proliferating spindle cells and cavernous blood vessels constitute the structure of SCH. SCH can present as vascular tumours in Maffucci's syndrome (MS). MS should be suspected when multifocal SCHs appear with enchondromas. This article is protected by copyright. All rights reserved.",
author = "Ho, {C B} and K Hsieh and Chen, {W Y} and Lin, {Y T} and Chiou, {J F} and Lee, {H L} and Shiah, {H S}",
note = "This article is protected by copyright. All rights reserved.",
year = "2018",
month = "5",
day = "11",
doi = "10.1111/bjd.16739",
language = "English",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Effective Sirolimus Treatment for Refractory Spindle Cell Haemangioma

AU - Ho, C B

AU - Hsieh, K

AU - Chen, W Y

AU - Lin, Y T

AU - Chiou, J F

AU - Lee, H L

AU - Shiah, H S

N1 - This article is protected by copyright. All rights reserved.

PY - 2018/5/11

Y1 - 2018/5/11

N2 - Spindle cell haemangioma (SCH), formerly known as spindle cell haemangioendothelioma, is a rare benign vascular tumour characterised by reactive vascular proliferation.1 The lesions mostly occur in the dermis and subcutaneous tissue of distal extremities. SCH is more common in children and young adults than other age groups, and it is equally prevalent in the sexes. Histologically, proliferating spindle cells and cavernous blood vessels constitute the structure of SCH. SCH can present as vascular tumours in Maffucci's syndrome (MS). MS should be suspected when multifocal SCHs appear with enchondromas. This article is protected by copyright. All rights reserved.

AB - Spindle cell haemangioma (SCH), formerly known as spindle cell haemangioendothelioma, is a rare benign vascular tumour characterised by reactive vascular proliferation.1 The lesions mostly occur in the dermis and subcutaneous tissue of distal extremities. SCH is more common in children and young adults than other age groups, and it is equally prevalent in the sexes. Histologically, proliferating spindle cells and cavernous blood vessels constitute the structure of SCH. SCH can present as vascular tumours in Maffucci's syndrome (MS). MS should be suspected when multifocal SCHs appear with enchondromas. This article is protected by copyright. All rights reserved.

U2 - 10.1111/bjd.16739

DO - 10.1111/bjd.16739

M3 - Article

JO - British Journal of Dermatology

JF - British Journal of Dermatology

SN - 0007-0963

ER -